Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention

Aims: Cardiovascular risk persists despite intensive lipid lowering therapy using statins. Serum levels of lipoprotein (a) [Lp(a)] can be a residual cardiovascular risk for adverse events. Aim of the present study was to evaluate the impact of Lp(a) on long-term clinical outcomes in patients treated...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Atheroscler Thromb
Autori principali: Suwa, Satoru, Ogita, Manabu, Miyauchi, Katsumi, Sonoda, Taketo, Konishi, Hirokazu, Tsuboi, Shuta, Wada, Hideki, Naito, Ryo, Dohi, Tomotaka, Kasai, Takatoshi, Okazaki, Shinya, Isoda, Kikuo, Daida, Hiroyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: Japan Atherosclerosis Society 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5684478/
https://ncbi.nlm.nih.gov/pubmed/28321012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.38794
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi